Health Rounds: Novel approach to HIV vaccine shows early promise

Blood sample taken from a child for an HIV test in Johannesburg, South Africa. (Reuters)
Short Url
Updated 16 May 2025
Follow

Health Rounds: Novel approach to HIV vaccine shows early promise

The first human clinical trials testing a new strategy to protect against HIV infections have yielded promising early results, according to two separate reports published on Thursday in Science.
The trials tested “germline targeting” HIV vaccines, which aim to activate immune system B cells in their naive, or germline, state, inducing them to become specialized cells that produce broadly neutralizing antibodies (bnAbs).
By delivering a variety of HIV immunogens – typically, viral protein fragments - germline vaccines train the B cells to produce antibodies that can recognize and block a broad range of different strains of HIV from infecting healthy cells.
Germline targeting requires an initial dose to prime the correct B cells, and subsequent doses to guide their maturation until they can produce effective bnAbs, the researchers reported.
"Across the participants we saw an immune response that indicates that we're on the right track,” Rogier Sanders of Amsterdam UMC, senior investigator on one of the trials, said in a statement.
“We saw that we can target the cells that we need to target with atomic precision. The next step is to further stimulate these cells to secrete broadly neutralizing antibodies," Sanders said.
In a separate paper, a different team of researchers reported on two early trials that used mRNA-encoded nanoparticles produced by Moderna to successfully prime the germline B cells, although a small proportion of patients had skin reactions to the vaccines.
The mRNA technology, similar to that used in Moderna's COVID-19 shots, would allow for faster vaccine development, the study authors said.
One of the trials was conducted in the United States and the other in Rwanda and South Africa. The majority of HIV patients live in Africa, but germline targeting has not previously been attempted there.
The researchers said the mRNA approach appeared to work with both North American and African populations, opening the door to further testing of germline-targeting vaccines for "African populations in most need of an HIV vaccine.”
EASING THERAPIES FOR SOME PROSTATE, CERVIX CANCERS
Two new studies suggest that patients with certain cancers might do just as well with a shorter course of radiation or a less extensive surgery as with standard treatments.
In JAMA Oncology, researchers reported that in men who require radiation after undergoing the most extensive type of surgery for prostate cancer, a form of high-dose radiation delivered in just five sessions known as stereotactic body radiotherapy (SBRT) appears to be as safe as conventional treatment delivered daily for up to seven weeks.
SBRT is a well-established treatment for prostate cancer, but its use after a radical prostatectomy has been limited due to concerns about the shifting position of the prostate bed and nearby healthy tissues.
The researchers tracked 100 men treated with SBRT in the single-arm study. Two years after the treatment, outcomes and side effects were similar to what the researchers had seen in the past from patients who received the longer-course treatments.
If randomized studies and longer follow-up confirm the results, “this approach could remove a major barrier to post-surgery radiation therapy,” study leader Dr. Amar Kishan of the David Geffen School of Medicine at UCLA said in a statement.
In JAMA Network Open, a separate team of researchers reported that women with low-risk early-stage cancer of the cervix do as well after simple hysterectomy as after modified radical hysterectomy or radical hysterectomy.
Among 2,636 carefully selected patients treated for stage IA2 or IB1 cervical carcinoma at accredited cancer hospitals, there was no difference in survival rates at 3 years, 5 years, 7 years or 10, or in postoperative outcomes after the three types of surgery.


French court rejects bid to reopen probe into black man’s death in custody

Updated 2 sec ago
Follow

French court rejects bid to reopen probe into black man’s death in custody

PARIS: France’s top court on Wednesday ruled against reopening an investigation into the 2016 death of a young black man in police custody, confirming a previous decision to dismiss the case against three arresting officers.
The Court of Cassation’s decision definitively closes the case nearly a decade after the death of 24-year-old Adama Traore following his arrest in the Paris suburb of Beaumont-sur-Oise, a fatality that triggered national outcry over police brutality and racism.
Traore’s family was contesting a 2024 appeal court ruling confirming a prior decision to drop the case, after an investigation led to no charges against the military policemen — or gendarmes — involved and therefore no case in court.
A lawyer representing his family announced after Wednesday’s ruling they would take the case to the European Court of Human Rights to “have France convicted.”
Three gendarmes pursued the young man on July 19, 2016, when temperatures reached nearly 37C, pinning him down in an apartment, after which he told officers he was “having trouble breathing.”
He then fainted during the journey to a gendarmerie station, where he died.
’Probably’ not fatal
In 2023, French investigating magistrates dropped the case against the three gendarmes, in a ruling that was upheld on appeal in 2024.
They had been tasked with probing whether the three arresting officers used disproportionate force against Traore during a police operation targeting his brother, Bagui.
According to the magistrates, Traore’s death was caused by heatstroke that “probably” would not have been fatal without the officers’ intervention — though it concluded their actions were within legal bounds.
His family however has accused the gendarmes of failing to help the young man, who was found by rescue services unconscious and handcuffed behind his back.
In their appeal, Traore’s family criticized the justice system for not carrying out a reconstitution of events as part of the investigation.
But prosecutors requested that the appeal be dismissed.
Internal investigations
Activists have repeatedly accused French police of violence and racism, but few cases make it to criminal court in France as most are dealt with internally.
In January, several thousand people protested in Paris over the death in custody of a Mauritanian immigrant worker, El Hacen Diarra, 35, who died after passing out at a police station following his violent arrest.
Paris police launched an internal investigation after video filmed by neighbors, shared on social media, showed a policeman punching what appears to be a man on the ground as another officer stands by and watches.
In 2024, a judge gave suspended jail sentences to three officers who inflicted irreversible rectal injuries to a black man, Theo Luhaka, during a stop-and-search in 2017.
Prosecutors have also called for a police officer to be tried over the 2023 killing of a teenager at a traffic stop, in a case that sparked nationwide protests.
A court is to rule in March whether he will face a criminal trial over the killing of 17-year-old Nahel M.
Europe’s top rights court in June condemned France over its police discriminating against a young man during identity checks, in the first such ruling against the country over alleged racial profiling.